FDA’s Gottlieb heads back to AEI to tackle drug prices

April 4, 2019

Source: Link

By Scott Gottlieb (Original source Washingotn Post)

“Scott Gottlieb, who will step down as commissioner of the Food and Drug Administration on Friday, plans to return to the American Enterprise Institute to focus on drug prices — a hotly debated area that has been peripheral to his current job, he said in an interview.

The 46-year-old physician, who has been commuting weekly to Washington from his home in Connecticut, said he plans to spend a half-dozen days a month in Washington as a resident fellow at the conservative think tank. Besides that, he said, he has no commitments for now other than taking his family to Disney World.

Gottlieb announced last month that he was leaving his post to spend more time with his wife and three young daughters. In a recent interview, he said he would explore other opportunities besides AEI at an appropriate time, “but I don’t know what they are right now.”’

Click here to see more

Relevant and recent posts

Jon Krohn: Top AI Insights from March

Jon Krohn rounds up March’s interviews in this ICYMI episode. Hear from AI and data science experts across the fields of education and business in…

Thought Leader: Jon Krohn

Dr. Sanjay Gupta: What’s Normal? A Real Talk on Gut Health

Even though everyone poops, most of us don’t really want to be reminded of that fact: we downright avoid discussing bowel habits with anyone — even our own doctor. But…

Thought Leader: Sanjay Gupta